Summary - CERT - NASDAQ - Weiss Ratings

E

Certara, Inc. CERT

$10.43 -$0.58-5.27%

Recommendation

Prev Close

Volume

Avg Vol (90D)

Market Cap

Dividend & Yield

--

52-Week Range

$9.41 - $19.22

P/E (TTM)

--

EPS (TTM)

My Lists My Alerts

Biotechnology Health Care Life Sciences Tools and Services Pharmaceutical

Rating

Reward

Risk

Rating Factors

Growth Index

Efficiency Index

Solvency Index

Total Return Index

Volatility Index

Dividend Index

--

Headlines

Bank of New York Mellon Corp Purchases 1,253,385 Shares of Certara, Inc. (NASDAQ:CERT)

3/11/2025 - MarketBeat

M&T Bank Corp Increases Stock Position in Certara, Inc. (NASDAQ:CERT)

3/10/2025 - MarketBeat

Certara, Inc. (CERT): Among the Cash-Rich Small Cap Stocks To Invest In According To Analysts

3/7/2025 - Insider Monkey

10 Cash-Rich Small Cap Stocks To Invest In According To Analysts

3/6/2025 - Insider Monkey

Certara Inc (CERT) Appoints Adrian McKemey as President of Drug Development Solutions

3/5/2025 - GuruFocus

Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions

3/5/2025 - GuruFocus

Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions

3/5/2025 - Globe Newswire

Analysts Have Conflicting Sentiments on These Healthcare Companies: Certara (CERT), Lantheus (LNTH) and Mirum Pharmaceuticals (MIRM)

3/3/2025 - TipRanks Financial Blog

Q1 Earnings Estimate for Certara Issued By Leerink Partnrs

3/3/2025 - MarketBeat

Certara (NASDAQ:CERT) Price Target Raised to $13.00

3/1/2025 - MarketBeat

Certara (CERT, $11.98) RSI Indicator left the oversold zone on February 28, 2025

3/1/2025 - Tickeron - Stocks

Certara (NASDAQ:CERT) Now Covered by TD Cowen

3/1/2025 - Ticker Report

Certara (NASDAQ:CERT) Shares Gap Up - Still a Buy?

2/28/2025 - MarketBeat

Certara Inc (CERT) Shares Gap Down to $11.84 on Feb 28

2/28/2025 - GuruFocus

Certara (NASDAQ:CERT) Earns Market Perform Rating from William Blair

2/28/2025 - MarketBeat

Stephens Reiterates "Overweight" Rating for Certara (NASDAQ:CERT)

2/28/2025 - MarketBeat

Certara, Inc. (NASDAQ:CERT) Receives Average Rating of "Hold" from Analysts

2/28/2025 - MarketBeat

Certara (NASDAQ:CERT) Now Covered by TD Cowen

2/28/2025 - MarketBeat

Certara (NASDAQ:CERT) Earns "Market Perform" Rating from William Blair

2/28/2025 - Ticker Report

Certara price target raised to $13 from $12 at Barclays

2/28/2025 - TipRanks Financial Blog

Certara price target raised by $1 at Barclays, here's why

2/28/2025 - The Fly

Decoding Certara Inc (CERT): A Strategic SWOT Insight

2/28/2025 - GuruFocus

Certara (NASDAQ:CERT) Announces Quarterly Earnings Results, Misses Expectations By $0.01 EPS

2/28/2025 - MarketBeat

Certara (NASDAQ:CERT) Issues FY 2025 Earnings Guidance

2/27/2025 - MarketBeat

Certara initiated with bullish view at TD Cowen, here's why

2/27/2025 - The Fly

Income Statement

Total Revenue (TTM)

EBITDA (TTM)

EBIT (TTM)

Net Income (TTM)

Balance Sheet

Total Assets (Q)

Total Debt (Q)

Total Liabilities (Q)

Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)

Cash from Investing (TTM)

Cash from Financing (TTM)

Net Change in Cash (TTM)

Filings

Filing Date

Wednesday, February 26, 2025

Period Date

Tuesday, December 31, 2024

Next Filing

Week of May 5 and 9 (est)

Price History

Loading...

Beta

7-Day Total Return

30-Day Total Return

60-Day Total Return

90-Day Total Return

Year to Date Total Return

1-Year Total Return

2-Year Total Return

3-Year Total Return

5-Year Total Return

--

52-week Low

Nov 21, 2024 - $9.41

52-week High

Mar 14, 2024 - $19.22

Valuation

Market Cap

$1.68B - Small Cap

Enterprise Value

Price/Sales (TTM)

Price/Book (Q)

Dividends and Shares

Shares Outstanding

Dividend Per Share (Most Recent)

--

Dividend Per Share (TTM)

--

Corporate Info

Website

www.certara.com

Phone Number

415 237 8272

Address

4 Radnor Corporate Center
Radnor, PA 19087

Country

Year Founded

Business Description

Sector

Industry

Health Care Equipment and Services

Certara, Inc., together with its subsidiaries, provides technology-enabled services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory... more